首页 | 本学科首页   官方微博 | 高级检索  
     


First‐in‐Man Study of the Low‐Dose Paclitaxel Using the COBRA‐P Drug‐Eluting Coronary Stent System With a Novel Biodegradable Coating in De Novo Coronary Lesions
Authors:Daisaku Nakatani MD  PhD  Katsuhisa Waseda MD  PhD  Junya Ako MD  PhD  Carlos Calderas MD  Jose A. Condado MD  Jose F. Condado MD  Yasuhiro Honda MD  Peter J. Fitzgerald MD  PhD
Affiliation:1. Division of Cardiovascular Medicine, Stanford University Medical Center, Stanford, California;2. Institute de Clinicas y Urologia Tamanaco Laboratorio de Hemodinamia, Caracas, Venezuela;3. Hospital Centro Medico de Caracas y Hospital Miguel Perez Carreno, Caracas, Venezuela
Abstract:
Keywords:drug‐eluting stent  intravascular ultrasound  incomplete stent apposition  neointimal hyperplasia
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号